Master Thesis in Immunology/Cancer Biology

Fachgebiet

Immunology

Arbeitsstätte

Vetmeduni Vienna

Website

sexl-lab.com

Bewerbungsfrist

30.06.2022

Ausschreibungstext

The institute of Pharmacology and Toxicology at the University of Veterinary Medicine Vienna is looking for a highly motivated master student to join the immunology/cancer biology research team and to investigate key pathways in B‐cell acute lymphoblastic leukemic (B‐ALL).

B‐ALL is the most common type of ALL and originates from immature B‐cell lymphoblasts. A subset of B‐ALL cases can be traced back to the BCR‐ABL1 fusion protein which drives the disease. While BCRABL1 tyrosine‐kinase inhibitors have been a major breakthrough in targeted cancer therapy, resistance mechanisms remain a challenge. We generated different tools to study BCR‐ABL1+ leukemia and investigate signaling pathways in the leukemic cells to explore possible vulnerabilities.

The successful applicant will join a dynamic multidisciplinary laboratory that is performing top‐level cancer research. The project involves work with primary cell culture, biochemical assays, flow cytometry an in vivo mouse models.

Candidate Profile:

* BSc Degree in Biology, Molecular Biology, Biotechnology, Biomedicine or a related subject

* Basic knowledge in immunology and tumor biology

* Experience with sterile cell culture work

* Fluent in English

* Previous experience with mouse work is beneficial

Application Details:

If you are interested and would like to be part of our team, please send a cover letter and a curriculum vitae to jana.trifinopoulos(at)vetmeduni.ac.at

Project start date: May‐June 2022

Financial support will be provided according to the guidelines of the FWF.

Kontakt-Person(en)

Haupt-Kontakt

Name: Jana Trifinopoulos

E-Mail: jana.trifinopoulos(at)vetmeduni.ac.at

Telefon: +431250772904